Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Health Outcomes of CAPABLE in Permanent Supportive Housing

14 novembre 2026 aggiornato da: Benjamin F. Henwood, University of Southern California

This study will evaluate whether Community Aging in Place-Advancing Better Living for Elders (CAPABLE) improves daily functioning among adults aged 45 years and older who live in permanent supportive housing and have difficulty performing everyday activities.

Participants will be randomly assigned to receive either CAPABLE in addition to their usual services or usual services alone. CAPABLE is a person-directed, home-based program delivered by an occupational therapist and a registered nurse. Participants assigned to CAPABLE may receive up to 10 home visits over approximately six months, including up to six occupational therapy visits and four nursing visits. Assistive devices and minor home modifications may also be provided based on each participant's goals and needs.

The study will enroll approximately 634 participants in Los Angeles County. Researchers will assess participants at enrollment and at 3, 6, 9, and 12 months. The main outcomes are participants' ability to perform activities of daily living and instrumental activities of daily living. The study will also examine health-related quality of life, health care use, housing stability, and the cost-effectiveness of CAPABLE.

Panoramica dello studio

Descrizione dettagliata

This randomized effectiveness trial will examine the effectiveness and cost-effectiveness of CAPABLE when delivered to adults living in permanent supportive housing. CAPABLE is a person-directed intervention designed to address functional limitations by integrating occupational therapy, nursing, assistive devices, and minor home modifications.

Approximately 634 participants will be randomly assigned in a 1:1 ratio to the CAPABLE intervention group or the usual-care control group. Participants assigned to CAPABLE will receive the intervention in addition to the health and supportive services normally available to them. The intervention may include up to six occupational therapy visits and four registered nursing visits over approximately six months. The occupational therapist and nurse will work with each participant to identify personal functional goals, assess barriers to achieving those goals, and develop individualized strategies. Assistive devices, minor home modifications, and coordination with existing health and supportive services will be provided when appropriate. Participants assigned to the control group will continue to receive their usual services.

Study assessments will occur at baseline and at 3, 6, 9, and 12 months. Full outcome assessments will be conducted at baseline, 6 months, and 12 months, with shorter assessments of health care utilization and health-related quality of life at 3 and 9 months. The primary outcomes are limitations in activities of daily living and instrumental activities of daily living. Additional outcomes include health-related quality of life, health care utilization, housing stability, and intervention costs.

Outcome assessors will be masked to participants' treatment assignments. The economic evaluation will compare intervention costs with changes in health-related quality of life and health care utilization to estimate the cost-effectiveness of CAPABLE relative to usual care.

Tipo di studio

Interventistico

Iscrizione (Stimato)

634

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

  • Nome: Benjamin F Henwood, PhD, MSW, MA
  • Numero di telefono: 213-821-0496
  • Email: bhenwood@usc.edu

Luoghi di studio

    • California
      • Los Angeles, California, Stati Uniti, 90089
        • University of Southern California
        • Contatto:
          • Benjamin F Henwood, PhD
          • Numero di telefono: 213-821-0496
          • Email: bhenwood@usc.edu

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

45 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Able and willing to provide informed consent
  • Client of the Los Angeles County Department of Health Services
  • Living in permanent supportive housing
  • Age 45 years or older
  • Cognitively intact or experiencing only mild cognitive impairment
  • Proficient in English or Spanish
  • Reports some or a lot of difficulty performing at least one activity of daily living or instrumental activity of daily living

Exclusion Criteria:

  • Does not meet one or more inclusion criteria
  • Unwilling or unable to provide informed consent
  • Withdraws consent

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Ricerca sui servizi sanitari
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: CAPABLE

Participants assigned to this arm will receive CAPABLE in addition to their usual health and supportive services. CAPABLE is a person-directed, home-based intervention delivered over approximately six months and may include up to six occupational therapy visits and four registered nursing visits. Assistive devices, minor home modifications, and coordination with existing services may be provided based on each participant's goals and needs.

CAPABLE is a person-directed, home-based behavioral intervention designed to improve participants' ability to perform everyday activities. The intervention is delivered over approximately six months and may include up to six visits from an occupational therapist and four visits from a registered nurse. The occupational therapist and nurse work with each participant to identify personal functional goals, assess barriers to achieving those goals, and develop individualized strategies. Assistive devices, minor home modifications, and coordination with existing health and supportive services may be provided as appropriate based on each participant's goals and needs.

Nessun intervento: Usual Care

Participants assigned to this arm will continue to receive the health and supportive services normally available to them and will not receive the CAPABLE intervention during the study.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in Activities of Daily Living Limitations
Lasso di tempo: Baseline, 6 months, and 12 months

Activities of daily living will be assessed using an 8-item scale measuring difficulty with basic daily activities. Each item is scored from 1 to 5, producing a total score ranging from 8 to 40. Higher scores indicate greater functional limitation. Change from baseline will be compared between study arms.

Baseline, 6 months, and 12 months
Change in Instrumental Activities of Daily Living Limitations
Lasso di tempo: Baseline, 6 months, and 12 months

Instrumental activities of daily living will be assessed using the 8-item Brief Instrumental Functioning Scale. Each item is scored from 1 to 5, producing a total score ranging from 8 to 40. Higher scores indicate greater functional limitation. Change from baseline will be compared between study arms.

Baseline, 6 months, and 12 months

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Quality-Adjusted Life Years
Lasso di tempo: Baseline and 3, 6, 9, and 12 months

Health-related quality of life will be measured using the five-item EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L). Responses will be converted to health-state utility values and used to calculate quality-adjusted life years over the 12-month follow-up period. Higher quality-adjusted life years indicate better health outcomes.

Baseline and 3, 6, 9, and 12 months
Health Care Utilization
Lasso di tempo: Baseline and 3, 6, 9, and 12 months

Health care utilization during the preceding three months will be assessed using the 12-item UCSD Healthcare Utilization Questionnaire. Participants will report their use of inpatient hospital care, surgery, nursing home care, emergency department care, ambulance services, outpatient health care, home care, telephone or online health care, prescription medications, and over-the-counter medications. Utilization will be compared between study arms and used to estimate health care costs.

Baseline and 3, 6, 9, and 12 months
Incremental Cost-Effectiveness of CAPABLE
Lasso di tempo: From baseline through 12 months

Incremental cost-effectiveness ratios will compare CAPABLE with usual care. Ratios will be calculated by dividing the difference between study arms in intervention and health care costs by the corresponding differences in activities of daily living limitations, instrumental activities of daily living limitations, and quality-adjusted life years. Lower costs per unit of improvement indicate greater cost-effectiveness.

From baseline through 12 months

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 marzo 2027

Completamento primario (Stimato)

31 agosto 2029

Completamento dello studio (Stimato)

31 agosto 2030

Date di iscrizione allo studio

Primo inviato

9 novembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

14 novembre 2026

Primo Inserito (Effettivo)

18 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

18 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

14 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

SÌ

Descrizione del piano IPD

A deidentified quantitative individual participant dataset will be shared. The study protocol, survey instruments, and data dictionary will also be made available to facilitate interpretation and reuse of the data. The dataset and associated documentation will be deposited in the National Archive of Computerized Data on Aging (NACDA), which is part of ICPSR.

Periodo di condivisione IPD

The IPD and supporting information will become available following completion of the planned study analyses and no later than August 31, 2031. Materials deposited in NACDA will remain available indefinitely.

Criteri di accesso alla condivisione IPD

Researchers will be able to access the deidentified individual participant dataset and supporting documentation through NACDA within ICPSR at no charge. Users must agree to the repository's terms of use, including limiting use to research or statistical purposes, not attempting to identify participants, not redistributing downloaded data, and properly citing the dataset.

Tipo di informazioni di supporto alla condivisione IPD

  • STUDIO_PROTOCOLLO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi